Iowa Senate Bill SF2151

Iowa 2025-2026 Regular Session

• Introduced: 1/29/26
• Refer: 1/29/26

Caption

A bill for an act removing psilocybin and psilocyn from the list of substances classified as schedule I controlled substances under Iowa's uniform controlled substances Act.

Impact

The removal of psilocybin and psilocyn from the Schedule I list could have significant implications for drug policy in Iowa. Supporters of the bill may argue that this change would open avenues for research into the medical benefits of these substances, particularly in mental health treatments for conditions like depression and PTSD. By revising the classification, the bill would align Iowa with a growing trend in other states that have recognized the therapeutic potential of psychedelics.

Summary

Senate File 2151, introduced by Senator Campbell, seeks to amend Iowa's Uniform Controlled Substances Act by removing psilocybin and psilocyn from the classification as Schedule I controlled substances. Currently, Schedule I substances are defined as those with a high potential for abuse and no accepted medical use in treatment. This bill aims to reclassify these substances, potentially allowing for medical research and therapeutic uses not previously possible under existing law.

Contention

Despite its potential benefits, this bill is likely to face opposition regarding public safety concerns. Opponents may express worries related to the possibility of increased recreational use and the societal implications of legitimizing substances that were previously considered dangerous. The discourse surrounding this legislation might include discussions on mental health, addiction, and community safety, highlighting a divide between progressive approaches to drug policy and traditional views on drug control.